Prentice Wealth Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-50
Closed -$1K 335
2021
Q3
$1K Sell
50
-50
-50% -$846 ﹤0.01% 341
2021
Q2
$2K Hold
100
﹤0.01% 303
2021
Q1
$3K Buy
+100
New +$2.51K ﹤0.01% 292

Other funds holding HSTO

Prentice Wealth Management's HSTO Position: Q4 2021 in Review

Prentice Wealth Management sold out of Histogen Inc. Common Stock (HSTO) in Q4 2021, closing a stake of 50 shares — an estimated $1K sold.

Prentice Wealth Management first reported a position in HSTO in Q1 2021 and held it in 3 quarters. The position peaked at $3K in Q1 2021. 24 funds tracked by Wall St. Rank hold HSTO as of Q4 2021.

  • Prentice Wealth Management reported no remaining Histogen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Prentice Wealth Management sold 50 Histogen Inc. Common Stock shares in Q4 2021, an estimated $1K.
  • Prentice Wealth Management first reported a position in Histogen Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Prentice Wealth Management's Histogen Inc. Common Stock position peaked at $3K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2021.

Based on Prentice Wealth Management's 13F filing for Q4 2021, filed 31 Oct 2022.